However, intriguingly, our subgroup analysis reveals a positive association between both IGF1 and 2 and an increased risk of endometrial cancer within the obese BMI category, translating to a substantial 3.5 and 3.7-fold increase in cancer risk, respectively. This evidence concerns the gene IGF1 and cancer.